Biol. Pharm. Bull. 30(1) 200—204 (2007)
ثبت نشده
چکیده
tients, and its blockade is believed to enable cancer patients to live longer. Thus, it is important to find promising antimetastatic agents. A variety of compounds have been shown to be benefitial for the inhibition of cancer metastasis. Some of them involve mechanisms based on the invasive inhibition of tumor cells by interfering with tumor adhesion to extracellular matrix components, inhibiting tumor cell-associated protease activity, or reducing the motile activity of tumor cells. Other compounds work through immunostimulation or through the inhibition of tumor-endothelial or -platelet interaction. Although these antimetastatic compounds have great potential for clinical applications, it remains critical to find compounds which may be much more effective. Antioxidants includes a variety of compounds having the ability of capturing reactive oxygen species; which are such as antioxidative vitamins and polyphenols. Antioxidants therefore have been proposed to have potential benefits for the prevention and treatment of diseases associated with reactive oxygen species. Especially in the cancer research field, antioxidants have been demonstrated to be effective in reducing the risk of carcinogenesis partly based on their antioxdative activity. Some antioxidants have also been shown to have other anti-cancer properties, which are inhibitory activities on cancer cell-derived proteases, cancer cell invasion and growth, and angiogenesis. Inhibitory activities on cancer metastasis have also been reported for some antioxidative vitamins, their analogues and some polyphenols in animal models; and their inhibitory mechanisms have been suggested to involve the inhibition of cancer cell invasion or angiogenesis, or the induction of apoptosis of cancer cells. It is important to note here that most of the in vivo experiments showing the efficacy of the compounds have been conducted in an experimental design evaluating their effect on the development of tumor micrometastasis, which suggests therapeutic values of compounds. In contrast, preventive activity of those compounds on the formation of tumor metastasis has not fully understood. The present comparative study examined the inhibitory activities against the in vitro invasion, growth and experimental lung metastasis of murine colon carcinoma cells of 20 antioxidants, including antioxidative vitamins and polyphenols.
منابع مشابه
Biol. Pharm. Bull. 30(9) 1599—1604 (2007)
In eukaryotic cells, combinatorial phosphorylation of the hydroxyl residues on the inositol ring of phosphatidylinositol (PtdIns) gives rise to seven phosphoinositides (eight if PtdIns itself is included) (Fig. 1). In the ‘canonical’ phosphoinositide (PI) cycles, phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P2] serves as a precursor of the intracellular second The Physiology of Phosphoinos...
متن کاملBiol. Pharm. Bull. 28(3) 563—564 (2005)
Tomomi NOGUCHI, Chihiro SHINJI, Hisayoshi KOBAYASHI, Makoto MAKISHIMA, Hiroyuki MIYACHI, and Yuichi HASHIMOTO* Institute of Molecular & Cellular Biosciences, The University of Tokyo; 1–1–1 Yayoi, Bunkyo-ku, Tokyo 113–0032, Japan: and Department of Biochemistry, Nihon University, School of Medicine; 30–1 Oyaguchi-kamicho, Itabashi-ku, Tokyo 173–8610, Japan. Received January 13, 2005; accepted Ja...
متن کاملBiol. Pharm. Bull. 30(3) 585—587 (2007)
major nosocomial pathogen, and biocides including antiseptics and disinfectants have been used in order to prevent its infections and spreading. Biocides have a wide variety of uses, and their concentrations and exposure times vary according to usage. Recently, MRSA isolates with decreased biocide susceptibilities have been isolated from clinical samples, and MRSA isolates carrying antiseptic-r...
متن کاملAntiinflammatory Constituents of Teramnus labialis
1. Alagarsamy, V., Raja Salomon, V., Vanikavitha, G., Paluchamy, V., Ravichandran, M., Arnold Sujin, A., Thangathirupathy, A., Amuthalakshmi, S. and Revathi R., Biol. Pharm. Bull., 2002, 25, 1432. 2. Alagarsamy, V., Muthukumar, V., Pavalarani, N., Vasanthanathan, P. and Revathi R., Biol. Pharm. Bull., 2003, 26(4), 557. 3. Chaurasia, M.R. and Sharma, S.K., Arch. Pharm., 1982, 315, 377. 4. Manabu...
متن کاملBiol. Pharm. Bull. 30(10) 1947—1949 (2007)
treat human immunodeficiency virus (HIV) type-1. According to in vitro experiments, DRV was active against HIV-1 with PI resistance mutations and against PI resistant clinical isolates. This drug is expected to be effective in antiretroviral treatment-experienced patients, such as those possessing HIV-1 strains which are resistant to more than one PI. Bouche et al. recently determined plasma DR...
متن کاملBiol. Pharm. Bull. 30(8) 1580—1585 (2007)
that was selected from a series of sulphonamide-substituted phenylethylamines. It blocks both postsynaptic a1and b1adrenoceptors to almost the same extent. When administered to conscious, spontaneously hypertensive rats, it reduces blood pressure via its a1-blocking activity without causing reflex tachycardia because of its b1-blocking action. This drug exhibited dose-dependent hypotensive effe...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2006